Close

TG Therapeutics (TGTX) Presents Encouraging Data from TG-1101 Phase 1b in NMO, NMOSD

Go back to TG Therapeutics (TGTX) Presents Encouraging Data from TG-1101 Phase 1b in NMO, NMOSD